Skip to main content
Premium Trial:

Request an Annual Quote

Ardais Raises $4 million in Private Financing

NEW YORK, Aug 12 (GenomeWeb News) - Ardais today announced that it has raised $4 million in a private round of financing.


The funds came from current investors, including Advanced Technology Ventures, Advent Health Care and Life Sciences, BioVentures Investors, EGS Healthcare Capital Partners, Federated Kaufmann Fund, Lancet Capital, Pequot Private Equity Fund, and Silicon Valley Bancshares.


The Lexington, Mass.-based firm said that it would use the cash infusion to accelerate commercialization of its new IT-based portfolio of biospecimen management solutions. Ardais said that its technology enables researchers at academic institutions and pharmaceutical/biotech companies to initiate and manage their own biorepositories.


The firm added that the financing would enable it to reach cash-flow breakeven.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.